pharma · Infertility in women undergoing assisted reproductive technologies (ART) · Intermediate risk, non-muscle invasive bladder cancer
Ferring Pharmaceuticals
Ferring Pharmaceuticals trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
-, St-Prex, 1162, CH, Mumbai HQ
1950 Founded
6,228 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- -, St-Prex, 1162, CH, Mumbai
- Founded
- 1950
- Employees
- 6,228
- Programs
- 13
- Drugs
- 23
- Patents
- 0
Ferring Pharmaceuticals clinical trials
Registry index of 13 ClinicalTrials.gov studies linked to Ferring Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
Ferring Pharmaceuticals trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Ferring Pharmaceuticals.
-
REKOVELLE for Idiopathic male infertility (in… — Phase 2
Clinical update -
000426 — Phase 1
Clinical update -
000414 — Phase 1
Clinical update -
TRI-001-01 — Phase 2
Clinical update -
000434 — Phase 3
Clinical update -
000427 — Phase 1
Clinical update -
Follitropin alfa — Phase 3
Clinical update -
Budesonide — Phase 1
Clinical update
Trial registry
-
CTIS ↗ -
CTIS ↗ -
CTIS ↗ - 2023-508430-34-00CTIS ↗
REKOVELLE for Idiopathic male infertility (in…
Idiopathic male infertility (including oligoasthenozoospermia).
-
CTIS ↗ - 2024-512177-27-01CTIS ↗
000434
High-risk Bacillus Calmette-Guerin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ(CIS) with or without papillary tumours
-
CTIS ↗ - 2024-517765-16-00CTIS ↗
TRI-001-01
Patients with Chronic Limb Threatening Ischemia (CLTI) due to Peripheral Arterial Disease (PAD)
-
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗